3-Methylpiperidine-4-carboxylic acid hydrochloride

Catalog No.: 
ACFVMP529
CAS No.: 
1038992-98-1
Molecular Formula: 
C7H14ClNO2
Molecular Weight: 
179.65
3-Methylpiperidine-4-carboxylic acid hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg97%$75.00In stockInquiry
1g97%$193.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-Methylpiperidine-4-carboxylic acid hydrochloride
IUPAC Name3-methylpiperidine-4-carboxylic acid hydrochloride
MDL No.MFCD21605305
Molecular FormulaC7H14ClNO2
Molecular Weight179.65
SMILESO=C(C1C(C)CNCC1)O.[H]Cl
InChI KeyIFRKXMIEHXHLNL-UHFFFAOYSA-N
SynonymEN300-153739 | 3-methylpiperidine-4-carboxylic acid;hydrochloride | IFRKXMIEHXHLNL-UHFFFAOYSA-N | SB15671 | CS-0056618 | AS-51555 | SB15670 | Z1795818158 | 3-methylpiperidine-4-carboxylic acid hcl | 3-methylpiperidine-4-carboxylicacidhydrochloride | 3-met
CAS No.1038992-98-1
PubChem CID69169077

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACFVMP529 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACWHVU561 route compound structure diagram
    ACWHVU5614021-12-9In Stock
  2. Then
  3. ACFVMP529 route product structure diagram
    ACFVMP5291038992-98-1In Stock
Inquiry

2. ACFVMP529 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACBMCQ485 route compound structure diagram
    ACBMCQ485512822-50-3In Stock
  2. Then
  3. ACFVMP529 route product structure diagram
    ACFVMP5291038992-98-1In Stock
Inquiry

3. ACFVMP529 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACFVMP529 route product structure diagram
    ACFVMP5291038992-98-1In Stock
Inquiry

Comments (0)